Related Experiment Video
Updated: May 14, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemia
Cyrus Khandanpour1, James D Phelan, Lothar Vassen
1Institut de recherches cliniques de Montréal (IRCM), 110 Avenue des Pins Ouest, Montréal, Quebec H2W 1R7, Canada.
Abstract:
Most patients with acute lymphoblastic leukemia (ALL) fail current treatments highlighting the need for better therapies. Because oncogenic signaling activates a p53-dependent DNA damage response and apoptosis, leukemic cells must devise appropriate countermeasures. We show here that growth factor independence 1 (Gfi1) can serve such a function because Gfi1 ablation exacerbates p53 responses and lowers the threshold for p53-induced cell death. Specifically, Gfi1 restricts p53 activity and expression of proapoptotic p53 targets such as Bax, Noxa (Pmaip1), and Puma (Bbc3). Subsequently, Gfi1 ablation cures mice from leukemia and limits the expansion of primary human T-ALL xenografts in mice. This suggests that targeting Gfi1 could improve the prognosis of patients with T-ALL or other lymphoid leukemias.
Insights
Growth factor independence 1 (Gfi1) restricts cancer cell death. Ablating Gfi1 enhances p53 responses, leading to leukemia cure in mice and potential new therapies for T-cell acute lymphoblastic leukemia (T-ALL).
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Acute lymphoblastic leukemia (ALL) often resists current treatments, necessitating novel therapeutic strategies.
- Leukemic cells employ mechanisms to evade apoptosis triggered by oncogenic signaling and p53 activation.
- Growth factor independence 1 (Gfi1) has been implicated in cellular processes relevant to cancer survival.
Purpose of the Study:
- To investigate the role of Growth factor independence 1 (Gfi1) in the context of acute lymphoblastic leukemia (ALL).
- To determine if Gfi1 influences the p53-dependent DNA damage response and apoptosis in leukemic cells.
- To evaluate the therapeutic potential of targeting Gfi1 in T-cell acute lymphoblastic leukemia (T-ALL).
Main Methods:
- Gfi1 gene ablation in mouse models of leukemia.
- Analysis of p53 pathway activation and expression of proapoptotic genes (Bax, Noxa, Puma).
- Assessment of leukemia progression and survival in Gfi1-ablated mice.
- Evaluation of Gfi1 targeting in human T-ALL xenografts.
Main Results:
- Gfi1 ablation potentiates p53 responses and lowers the threshold for p53-induced apoptosis.
- Gfi1 restricts p53 activity and the expression of key proapoptotic targets.
- Gfi1 deficiency leads to leukemia remission in mice.
- Gfi1 ablation inhibits the growth of primary human T-ALL xenografts.
Conclusions:
- Gfi1 plays a critical role in suppressing p53-mediated apoptosis in ALL.
- Targeting Gfi1 represents a promising therapeutic strategy for T-ALL and potentially other lymphoid leukemias.
- Gfi1 inhibition may overcome treatment resistance in ALL patients.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway

